Citigroup
ONCY icon

Citigroup’s Oncolytics Biotech ONCY Stock Holding History

Citigroup’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$81.2K Buy
121,462
+92,239
+316% +$74.9K ﹤0.01% 4543
2026
Q2 		$27.8K Buy
+29,223
New +$27.1K ﹤0.01% 5100
2026
Q1 		– Sell
-1
Closed -$1 – 6266
2025
Q4 		$1 Buy
+1
New +$1 ﹤0.01% 5982
2025
Q3 		– Sell
-333
Closed -$254 – 6245
2025
Q2 		$254 Buy
+333
New +$176 ﹤0.01% 5469
2018
Q3 		– Sell
-947
Closed -$5K – 7832
2018
Q2 		$5K Buy
+947
New +$5.83K ﹤0.01% 7352

Other funds holding ONCY

IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 22.25% 1-Year Est. Return
Larson Financial Group
Larson Financial Group St Louis, Missouri $4.11B AUM 23.62% 1-Year Est. Return
Everhart Financial Group
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
Doliver Advisors
Doliver Advisors Houston, Texas $458M AUM 38.24% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.2B AUM 25.19% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Badgley Phelps Wealth Managers
Badgley Phelps Wealth Managers Seattle, Washington $5.8B AUM 25.34% 1-Year Est. Return
Clearstead Advisors
Clearstead Advisors Cleveland, Ohio $10.8B AUM 17.88% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
StoneX Group
StoneX Group New York $2.75B AUM 24.25% 1-Year Est. Return

Citigroup's ONCY Position: Q3 2026 in Review

Citigroup increased its Oncolytics Biotech (ONCY) stake by 316% in Q3 2026, buying an estimated $74.9K and bringing the position to 121,462 shares worth $81.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4543.

Citigroup first reported a position in ONCY in Q2 2018 and has held it in 5 quarters since. 33 funds tracked by Wall St. Rank hold ONCY as of Q3 2026.

  • Citigroup held 121,462 shares of Oncolytics Biotech worth $81.2K as of Q3 2026.
  • Citigroup bought 92,239 Oncolytics Biotech shares in Q3 2026, an estimated $74.9K.
  • Oncolytics Biotech made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #4543 holding.
  • Citigroup first reported a position in Oncolytics Biotech in Q2 2018 and has held it in 5 quarters since.
  • 33 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.